These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Knowledge and practice of patient-derived xenograft models in leukemia]. Kato I Rinsho Ketsueki; 2022; 63(9):1335-1343. PubMed ID: 36198560 [TBL] [Abstract][Full Text] [Related]
24. Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts. Mer AS; Ba-Alawi W; Smirnov P; Wang YX; Brew B; Ortmann J; Tsao MS; Cescon DW; Goldenberg A; Haibe-Kains B Cancer Res; 2019 Sep; 79(17):4539-4550. PubMed ID: 31142512 [TBL] [Abstract][Full Text] [Related]
25. The future of patient-derived tumor xenografts in cancer treatment. Sia D; Moeini A; Labgaa I; Villanueva A Pharmacogenomics; 2015; 16(14):1671-83. PubMed ID: 26402657 [TBL] [Abstract][Full Text] [Related]
26. Patient-Derived Xenografts: A Valuable Preclinical Model for Drug Development and Biomarker Discovery. Weng T; Jenkins BJ; Saad MI Methods Mol Biol; 2024; 2806():19-30. PubMed ID: 38676793 [TBL] [Abstract][Full Text] [Related]
27. Towards precision oncology with patient-derived xenografts. Zanella ER; Grassi E; Trusolino L Nat Rev Clin Oncol; 2022 Nov; 19(11):719-732. PubMed ID: 36151307 [TBL] [Abstract][Full Text] [Related]
28. Patient-Derived Xenograft Models in Breast Cancer Research. Na D; Moon HG Adv Exp Med Biol; 2021; 1187():283-301. PubMed ID: 33983584 [TBL] [Abstract][Full Text] [Related]
29. Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments. Zarzosa P; Navarro N; Giralt I; Molist C; Almazán-Moga A; Vidal I; Soriano A; Segura MF; Hladun R; Villanueva A; Gallego S; Roma J Clin Transl Oncol; 2017 Jan; 19(1):44-50. PubMed ID: 27718156 [TBL] [Abstract][Full Text] [Related]
30. The EurOPDX Data Portal: an open platform for patient-derived cancer xenograft data sharing and visualization. Dudová Z; Conte N; Mason J; Stuchlík D; Peša R; Halmagyi C; Perova Z; Mosaku A; Thorne R; Follette A; Pivarč Ľ; Šašinka R; Usman M; Neuhauser S; Begley DA; Krupke DM; Frassà M; Fiori A; Corsi R; Vezzadini L; Isella C; Bertotti A; Bult C; Parkinson H; Medico E; Meehan T; Křenek A BMC Genomics; 2022 Feb; 23(1):156. PubMed ID: 35193494 [TBL] [Abstract][Full Text] [Related]
32. Patient-derived xenograft models in musculoskeletal malignancies. Lu W; Chao T; Ruiqi C; Juan S; Zhihong L J Transl Med; 2018 Apr; 16(1):107. PubMed ID: 29688859 [TBL] [Abstract][Full Text] [Related]
33. Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies. Heo EJ; Cho YJ; Cho WC; Hong JE; Jeon HK; Oh DY; Choi YL; Song SY; Choi JJ; Bae DS; Lee YY; Choi CH; Kim TJ; Park WY; Kim BG; Lee JW Cancer Res Treat; 2017 Oct; 49(4):915-926. PubMed ID: 28052650 [TBL] [Abstract][Full Text] [Related]
34. Patient-derived xenograft models of neuroendocrine prostate cancer. Shi M; Wang Y; Lin D; Wang Y Cancer Lett; 2022 Jan; 525():160-169. PubMed ID: 34767925 [TBL] [Abstract][Full Text] [Related]
35. The Power and Promise of Patient-Derived Xenografts of Human Breast Cancer. Lewis MT; Caldas C Cold Spring Harb Perspect Med; 2024 Apr; 14(4):. PubMed ID: 38052483 [TBL] [Abstract][Full Text] [Related]
36. Patient-derived xenograft models for personalized medicine in colorectal cancer. Xie J; Lin Y Clin Exp Med; 2020 May; 20(2):167-172. PubMed ID: 32100151 [TBL] [Abstract][Full Text] [Related]
37. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research. Kawaguchi T; Foster BA; Young J; Takabe K J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789 [TBL] [Abstract][Full Text] [Related]
38. Subrenal capsule grafting technology in human cancer modeling and translational cancer research. Wang Y; Wang JX; Xue H; Lin D; Dong X; Gout PW; Gao X; Pang J Differentiation; 2016; 91(4-5):15-9. PubMed ID: 26547391 [TBL] [Abstract][Full Text] [Related]
39. Development and Expansion of Patient-Derived Xenografts for Endometrial Cancer. Sengal AT; Pollock PM Methods Mol Biol; 2024; 2806():101-115. PubMed ID: 38676799 [TBL] [Abstract][Full Text] [Related]
40. Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers. Lan T; Xue X; Dunmall LC; Miao J; Wang Y Aging (Albany NY); 2021 Apr; 13(8):12273-12293. PubMed ID: 33903283 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]